Pediatric group B coxsackievirus infections

Current Topics in Microbiology and Immunology

Volumn 323, Issue , 2008, Pages 223-239

  Romero, J R ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; ORAL CONTRACEPTIVE AGENT; PLACEBO; PLECONARIL;

BLOOD CLOTTING DISORDER; BRONCHIOLITIS; BRONCHITIS; CENTRAL NERVOUS SYSTEM INFECTION; CHILDHOOD DISEASE; CLINICAL TRIAL; COXSACKIE VIRUS B; COXSACKIE VIRUS INFECTION; CROUP; DIAGNOSTIC PROCEDURE; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG MECHANISM; ENTEROVIRUS INFECTION; EXANTHEMA SUBITUM; FEVER; HEADACHE; HEPATITIS; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; MACULOPAPULAR RASH; MENINGOENCEPHALITIS; MYOCARDITIS; NAUSEA; NONHUMAN; OTITIS MEDIA; PAROTITIS; PETECHIA; PHARYNGITIS; PICORNAVIRUS INFECTION; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; STOMATITIS; SUMMER COLD; URTICARIA; VIRAL UPPER RESPIRATORY TRACT INFECTION; VIREMIA; VIRUS MENINGITIS; CHILD; ENTEROVIRUS; MUSCULOSKELETAL DISEASE; RESPIRATORY TRACT INFECTION; SYNDROME; VIRAL SKIN DISEASE; VIROLOGY;

COXSACKIEVIRUS;

CENTRAL NERVOUS SYSTEM VIRAL DISEASES; CHILD; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; HUMANS; MUSCULOSKELETAL DISEASES; RESPIRATORY TRACT INFECTIONS; SKIN DISEASES, VIRAL; SYNDROME;

EID: 43649084269     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-75546-3_10     Document Type: Review

References (109)

1. Abdel-Rahman SM, Kearns GL (1998) Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution and effect of food. Antimicrob Agents Chemother 42:2706-2709
2. Abdel-Rahman SM, Kearns GL (1999) Single oral dose escalation pharmacokinetics of pleconaril (VP 63843) capsules in adults. J Clin Pharmacol 39:613-618
3. Abzug MJ (2001) Prognosis for neonates with enterovirus hepatitis and coagulopathy. Pediatr Infect Dis J 20:758-763
4. Abzug MJ (2004) Presentation, diagnosis, and management of enterovirus infections in neonates. Paediatr Drugs 6:1-10
5. Abzug MJ, Cloud G, Bradley J, Sanchez P, Romero J, Powell D, Lepow M, Mani C, Capparelli EV, Blount S, Lakeman F, Whitley RJ, Kimberlin DW, Collaborative Antiviral Study Group (2003) Double blind, placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr Infect Dis J 22:335-341
6. Alexander JP Jr, Chapman LE, Pallansch MA, Stephenson WT, Torok TJ, Anderson LJ (1993) Coxsackievirus B2 infection and aseptic meningitis: a focal outbreak among members of a high school football team. J Infect Dis 167:1201-1205
7. Aradottir E, Alonso EM, Shulman ST (2001) Severe neonatal enteroviral hepatitis treated with pleconaril. Pediatr Infect Dis J 20:457-459
8. Arrieta AC, Stutman HR (1991) Coxsackie B2 meningitis with unusually high white blood cell count in cerebrospinal fluid. Pediatr Infect Dis J 10:250-251
9. Bain HW, McLean DM, Walkere SJ (1961) Epidemic pleurodynia (Bornholm disease) due to Coxsackie B-5 virus. The inter-relationship of pleurodynia, benign pericarditis and aseptic meningitis. Pediatrics 27:889-903
10. Baker DA, Phillips (1980) CA maternal and neonatal infection with coxsackievirus Obstet Gynecol 55(3 Suppl):12S-15S
11. Bates HR Jr (1970) Coxsackie virus B3 calcific pancarditis and hydrops fetalis. Am J Obstet Gynecol 106:629-630
12. Bauer S, Gottesman G, Sirota L, Litmanovitz I, Ashkenazi S, Levi I (2002) Severe Coxsackie virus B infection in preterm newborns treated with pleconaril. Eur J Pediatr 161:491-493
13. Bendig JW, Franklin OM, Hebden AK, Backhouse PJ, Clewley JP, Goldman AP, Piggott N (2003) Coxsackievirus B3 sequences in the blood of a neonate with congenital myocarditis, plus serological evidence of maternal infection. J Med Virol 70:606-609
14. Berlin LE, Rorabaugh ML, Heldrich F, Roberts K, Doran T, Modlin JF (1993) Aseptic meningitis in infants <2 years of age: diagnosis and etiology. J Infect Dis 168:888-892
15. Brightman VJ, Scott TF, Westphal M Boggs TR (1966) An outbreak of coxsackie B-5 virus infection in a newborn nursery. J Pediatr 69:179-192
16. Buontempo PJ, Cox S, Wright-Minogue J, DeMartino JL, Skelton AM, Ferrari E, Albin R, Rozhon EJ, Girijavallabhan V, Modlin JF, O'Connell JF (1997) SCH 48973 a potent, broad-spectrum, antienterovirus compound. Antimicrob Agents Chemother 41:1220-1225
17. Burch GE, Sun SC, Chu K, Sohal RS, Colcolough HL (1968) Interstitial and coxsackievirus B myocarditis in infants and children. A comparative histologic and immunofluorescent study of 50 autopsied hearts. JAMA 203:1-8
18. Byington CL, Taggart EW, Carroll KC, Hillyard DR (1999) A polymerase chain reaction-based epidemiologic investigation of the incidence of nonpolio enteroviral infections in febrile and afebrile infants 90 days and younger. Pediatrics 103:E27
19. Carmichael J, McGuckin R, Gardner PS (1968) Outbreak of Coxsackie type B2 virus in a children's home in Newcastle upon Tyne. BMJ 2:532-533
20. Centers for Disease Control and Prevention (2006) Enterovirus Surveillance- United States 1970-2005 MMWR 55:1-20
21. Chambon M, Archimbaud C, Bailly JL, Henquell C, Regagnon C, Charbonne F, Peigue-Lafeuille H (2001) Circulation of enteroviruses and persistence of meningitis cases in the winter of 1999-2000. J Med Virol 65:340-347
22. Charney EB, Orecchio EJ, Zimmerman RA, Berman PH (1979) Computerized tomography in infantile encephalitis. Am J Dis Child 133:803-805
23. Chemtob S, Reece ER, Mills EL (1985) Syndrome of inappropriate secretion of antidiuretic hormone in enteroviral meningitis. Am J Dis Child 139:292-294
24. Cherry JD (2004) Enteroviruses and parechoviruses. In: Feigin RD, Cherry JD, Demmler G, Kaplan SL (eds) Textbook of pediatric infectious diseases, 5th edn, vol. 2. Saunders, Philadelphia, pp 1984-2041
25. Cherry JD, Jahn CL (1965) Herpangina: the etiologic spectrum. Pediatrics 36:632-634
26. Chesney JC, Hoganson GE, Wilson MH (1980) CSF eosinophilia during an acute coxsackie B4 viral meningitis. Am J Dis Child 134:703
27. Chesney PJ, Quennec P, Clark C (1978) Hypoglycorrhachia and coxsackie B3 meningoencephalitis. Am J Clin Pathol 70:947-948
28. Chiou CC, Liu WT, Chen SJ, Soong WJ, Wu KG, Tang RB, Hwang B (1998) Coxsackievirus B1 infection in infants less than 2 months of age. Am J Perinatol 15:155-159
29. Chonmaitree T, Mann L (1995) Respiratory Infections. In: Rotbart HA (ed) Human enterovirus infections. American Society of Microbiology, Washington DC, pp 255-270
30. Chonmaitree T, Ford C, Sanders C, Lucia HL (1988) Comparison of cell cultures for rapid isolation of enteroviruses. J Clin Microbiol 26:2576-2580
31. Chou LL, Chang CP, Wu LC (1995) Neonatal coxsackievirus B1 infection associated with severe hepatitis: report of three cases. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 36:296-299
32. Clavell M, Barkemeyer B, Martinez B, Craver R, Correa H, Gohd R, Schmidt-Sommerfeld E (1999) Severe hepatitis in a newborn with coxsackievirus B5 infection. Clin Pediatr (Phila) 38:739-741
33. Curnen EC, Shaw EW, Melnick JL (1949) Disease resembling nonparalytic poliomyelitis associated with a virus pathogenic for infant mice. JAMA 141:894-901
34. Dagan R, Hall CB, Powell KR, Menegus MA (1989) Epidemiology and laboratory diagnosis of infection with viral and bacterial pathogens in infants hospitalized for suspected sepsis. J Pediatr 115:351-356
35. Desmond RA, Accortt NA, Talley L, Villano SA, Soong SJ, Whitley RJ (2006) Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrob Agents Chemother 50:2409-2414
36. Dietz V, Andrus J, Olive JM, Cochi S, de Quadros C (1995) Epidemiology and clinical characteristics of acute flaccid paralysis associated with non-polio enterovirus isolation: the experience in the Americas. Bull World Health Organ 73:597-603
37. Dorries R, Ter Meulen V (1983) Specificity of IgM antibodies in acute human coxsackievirus B infections, analysed by indirect solid phase enzyme immunoassay and immunoblot technique. 64:159-167
38. Eckert HL, Portnoy B, Salvatore MA, Ressler R (1967) Group B Coxsackie virus infection in infants with acute lower respiratory disease. Pediatrics 39:526-531
39. Eilard T, Kyllerman M, Wennerblom I, Eeg-Olofsson O, Lycke E (1974) An outbreak of Coxsackie virus type B2 among neonates in an obstetrical ward. Acta Paediatr Scand 63:103-107
40. Farmer K, Patten PT (1968) An outbreak of coxsackie B5 infection in a special care unit for newborn infants. N Z Med J 68:86-89
41. Flewet TH (1965) Histological study of two cases of Coxsackie B virus pneumonia in children. J Clin Path 18:743-736
42. Goldwater PN (1995) Immunoglobulin M capture immunoassay in investigation of coxsackievirus B5 and B6 outbreaks in south Australia. J Clin Microbiol 33:1628-1631
43. Hable KA, O'Connell EJ, Herrmann EC Jr (1970) Group B coxsackieviruses as respiratory viruses. Mayo Clin Proc 45:170-176
44. Hall CB, Miller DG (1969) The detection of a silent coxsackie B-5 virus perinatal infection. J Pediatr 75:124-127
45. Heathfield KW, Pilsworth R, Wall BJ, Corsellis JA (1967) Coxsackie B5 infections in Essex, 1965, with particular reference to the nervous system. Q J Med 36:579-595
46. Hornung TS, Bernard EJ, Howman-Giles RB, Sholler GF (1999) Myocardial infarction complicating neonatal enterovirus myocarditis. J Paediatr Child Health 35:309-312
47. Horstmann DM, Yamada N (1968) Enterovirus infections of the central nervous system. Res Publ Assoc Res Nerv Ment Dis 44:236-253
48. Huebner RJ, Risser JA, Bell JA, Beeman EA, Beigelman PM, Strong JC (1953) Epidemic pleurodynia in Texas; a study of 22 cases. N Engl J Med 248:267-274
49. Isacsohn M, Eidelman AI, Kaplan M, Goren A, Rudensky B, Handsher R, Barak Y (1994) Neonatal coxsackievirus group B infections: experience of a single department of neonatology. Isr J Med Sci 30:371-374
50. Jaffe M, Srugo I, Tirosh E, Colin AA, Tal Y (1989) The ameliorating effect of lumbar puncture in viral meningitis. Am J Dis Child 143:682-685
51. Jenista JA, Powell KR, Menegus MA (1984) Epidemiology of neonatal enterovirus infection. J Pediatr 104:685-690
52. Johnston JM, Overall JC Jr (1989) Intravenous immunoglobulin in disseminated neonatal echovirus 11 infection. Pediatr Infect Dis J 8:254-256
53. Kaiser L, Crump CE, Hayden FG (2000) In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses. Antiviral Res 47:215-220
54. Kaplan MH, Klein SW, McPhee J, Harper RG (1983) Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev Infect Dis 5:1019-1032
55. Kearns GL, Bradley JS, Jacobs RF, Capparelli EV, James LP, Johnson KM, Abdel-Rahman SM (2000) Single dose pharmacokinetics of pleconaril in neonates. Pediatr Infect Dis J 19: 833-839
56. Khetsuriani N, Lamonte A, Oberste MS, Pallansch M (2006) Neonatal enterovirus infections reported to the national enterovirus surveillance system in the United States 1983-2003. Pediatr Infect Dis J 25:889-893
57. Kibrick S, Benirschke K (1958) Severe generalized disease (encephalohepatomyocarditis) occurring in the newborn period and due to infection with coxsackie virus, group B: evidence of intrauterine infection with this agent. Pediatrics 22:857-874
58. Kimura H, Minakami H, Harigaya A, Takeuchi H, Tachibana A, Otsuki K (1999) Treatment of neonatal infection caused by coxsackievirus B3. J Perinatol 19:388-390
59. Klespies SL, Cebula DE, Kelley CL, Galehouse D, Maurer CC (1996) Detection of enteroviruses from clinical specimens by spin amplification shell vial culture and monoclonal antibody assay. J Clin Microbiol 34:1465-1467
60. Krajden S, Middleton PJ (1983) Enterovirus infections in the neonate. Clin Pediatr (Phila) 22:87-92
61. Lake AM, Lauer BA, Clark JC, Wesenberg RL, McIntosh K (1976) Enterovirus infections in neonates. J Pediatr 89:787-791
62. Leggiadro RJ, Darras BT (1983) Viral and bacterial pathogens of suspected sepsis in young infants. Pediatr Infect Dis 2:287-289
63. Lu JC, Koay KW, Ramers CB, Milazzo AS (2005) Neonate with coxsackie B1 infection, cardiomyopathy and arrhythmias. JAMA 97:1028-1030
64. McKinney RE Jr, Katz SL, Wilfert CM (1987) Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis 9:334-356
65. McKinlay MA, Pevear DC, Rossmann MG (1992) Treatment of the picornavirus common cold by inhibitors of viral uncoating and attachment. Ann Rev Microbiol 46:635-654
66. Modlin JF, Rotbart HA (1997) Group B coxsackie disease in children. Curr Top Microbiol Immunol 223:53-80
67. Modlin JF, Polk BF, Horton P, Etkind P, Crane E, Spiliotes A (1981) Perinatal echovirus infection: risk of transmission during a community outbreak. N Engl J Med 305:368-371
68. Modlin JF, Dagan R, Berlin LE, Virshup DM, Yolken RH, Menegus M (1991) Focal encephalitis with enterovirus infections. Pediatrics 88:841-845
69. Moore M, Kaplan MH, McPhee J, Bregman DJ, Klein SW (1984) Epidemiologic, clinical, and laboratory features of Coxsackie B1-B5 infections in the United States, 1970-79. Public Health Rep 99:515-522
70. Murry DL (1996) Neonatal enterovirus infection: neutralization by intravenous immune globulin. Clin Infect Dis 22:397-398
71. Valduss D, Murray DL, Karna P, Lapour K, Dyke J (1993) Use of intravenous immunoglobulin in twin neonates with disseminated coxsackie B1 infection. Clin Pediatr (Phila) 32:561-563
72. Nakayama T, Urano T, Osano M, Hayashi Y, Sekine S, Ando T, Makinom S (1989) Outbreak of herpangina associated with Coxsackievirus B3 infection. Pediatr Infect Dis J 8: 495-498
73. Nix WA, Oberste MS, Pallansch MA (2006) Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol 44:2698-2704
74. Nowak-Wegrzyn A, Phipatanakul W, Winkelstein JA, Forman MS, Lederman HM (2001) Successful treatment of enterovirus infection with the use of pleconaril in 2 infants with severe combined immunodeficiency. Clin Infect Dis 32:E13-E14
75. Oberste MS, Maher K, Kilpatrick DR, Flemister MR, Brown BA, Pallansch MA (1999) Typing of human enteroviruses by partial sequencing of VP1. J Clin Microbiol 37:1288-1293
76. Oberste MS, Nix WA, Maher K, Pallansch MA (2003) Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. J Clin Virol 26:375-377
77. Otero JR, Folgueira L, Trallero G, Prieto C, Maldonado S, Babiano MJ, Martinez-Alonso I (2001) A-549 is a suitable cell line for primary isolation of coxsackie B viruses. J Med Virol 65:534-536
78. Ouellet A, Sherlock R, Toye B, Fung KF (2004) Antenatal diagnosis of intrauterine infection with coxsackievirus B3 associated with live birth. Infect Dis Obstet Gynecol 12:23-26
79. Parrott RH, Ross S, Burke FG, Rice EC (1951) Herpangina; clinical studies of a specific infectious disease. N Engl J Med 245:275-280
80. Quartier P, Foray S, Casanova JL, Hau-Rainsard I, Blanche S, Fischer A (2000) Enteroviral meningoencephalitis in X-linked agammaglobulinemia: intensive immunoglobulin therapy and sequential viral detection in cerebrospinal fluid by polymerase chain reaction. Pediatr Infect Dis J 19:1106-1108
81. Rantakallio P, Lapinleimu K, Mantyjarvi R (1970) Coxsackie B 5 outbreak in a newborn nursery with 17 cases of serous meningitis. Scand J Infect Dis 2:17-23
82. Reigel F (1985) Isolation of human pathogenic viruses from clinical material on CaCo2 cells. J Virol Methods 12:323-327
83. Reiss-Levy E, Baker A, Don A, Caldwell G (1986) Two concurrent epidemics of enteroviral meningitis in an obstetric neonatal unit. Aust N Z J Med 16:365-372
84. Rentz AC, Libbey JE, Fujinami RS, Whitby FG, Byington CL (2006) Investigation of treatment failure in neonatal echovirus 7 infection. Pediatr Infect Dis J 25:259-262
85. Rogers JM, Diana GD, MCKinlay MA (1999) Pleconaril. A broad spectrum antipicornaviral agent. Adv Exp Med Biol 458:69-76
86. Romero JR (1999) Reverse-transcription polymerase chain reaction detection of the enteroviruses. Arch Pathol Lab Med 123:1161-1169
87. Romero JR (2001) Pleconaril: a novel antipicornaviral drug. Expert Opin Investig Drugs 10:369-379
88. Romero JR (2006) Entroviruses and parechoviruses. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (eds) Manual of clinical microbiology, 9th edn. American Society for Microbiology, Washington DC, pp 1392-1404
89. Rorabaugh ML, Berlin LE, Heldrich F, Roberts K, Rosenberg LA, Doran T, Modlin JF (1993) Aseptic meningitis in infants younger than 2 years of age: acute illness and neurologic complications. Pediatrics 92:206-211
90. Rotbart HA (1995) Enteroviral infections of the central nervous system. Clin Infect Dis 20:971-981
91. Rotbart HA, Webster AD (2001) Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin Infect Dis 32:228-235
92. Ryder DE, Doane FW, Zbitnew A, Rhodes AJ (1959) Report of an outbreak of Bornholm disease, with isolation of Coxsackie B5 virus: Toronto, 1958. Can J Public Health 50:265-269
93. Sawyer MH, Saez-Llorenz X, Avilles CL, O'Ryan M, Romero J (1999) Oral pleconaril reduces the duration and severity of enteroviral meningitis in children. Pediatric Academic Societies' Annual Meeting, San Francisco, CA, Abstr 1012
94. Schiff GM (1979) Coxsackievirus B epidemic at a boys' camp. Am J Dis Children 133:782-785
95. Severien C, Jacobs KH, Schoenemann W (1994) Marked pleocytosis and hypoglycorrhachia in coxsackie meningitis. Pediatr Infect Dis J 13:322-323
96. Shah SS, Hellenbrand WE, Gallagher PG (1998) A trial flutter complicating neonatal Coxsackie B2 myocarditis. Pediatr Cardiol 19:185-186
97. Singer JI, Maur PR, Riley JP, Smith PB (1980) Management of central nervous system infections during an epidemic of enteroviral aseptic meningitis. J Pediatr 96:559-563
98. Swender PT, Shott RJ, Williams ML (1974) A community and intensive care nursery outbreak of coxsackievirus B5 meningitis. Am J Dis Child 127:42-45
99. Sylvest E (1934) Epidemic myalgia: Bornholm disease. Andersen H (transl). London, Oxford University Press
100. Valduss D, Murray DL, Karna P, Lapour K, Dyke J (1993) Use of intravenous immunoglobulin in twin neonates with disseminated coxsackie B1 infection. Clin Pediatr (Phila) 32:561-563
101. Van Doornum GJ, De Jong JC (1998) Rapid shell vial culture technique for detection of enteroviruses and adenoviruses in fecal specimens: comparison with conventional virus isolation method. J Clin Microbiol 36:2865-2868
102. Wallot MA, Metzger-Boddien C, Auth M, Kehle J, Enders G, Dirsch O, Fiedler M, Voit T (2004) Acute liver failure associated with Coxsackie virus B2 infection in a neonate. Eur J Pediatr 163:116-117
103. Wang SM, Liu CC, Yang YJ, Yang HB, Lin CH, Wang JR (1998) Fatal coxsackievirus B infection in early infancy characterized by fulminant hepatitis. J Infect 37:270-273
104. Weller TH, Enders JF, Buckingham M, Finn JJ Jr (1950) The etiology of epidemic pleurodynia: a study of two viruses isolated from a typical outbreak. J Immunol 65:337-346
105. Wilfert CM, Lehrman SN, Katz SL (1983) Enteroviruses and meningitis. Pediatr Infect Dis 2:333-334
106. Witherell G (2000) AG-7088 Pfizer. Curr Opin Investig Drugs 1:297-302
107. Wong SN, Tam AY, Ng TH, Ng WF, Tong CY, Tang TS (1989) Fatal Coxsackie B1 virus infection in neonates. Pediatr Infect Dis J 8:638-641
108. Zahorsky J (1920) Herpetic sore throat. South Med J 13:871
109. Zahorsky J (1924) Herpangina. Arch Pediatr 41:181